APLN and type 2 diabetes mellitus: Apelin is an adipokine, a bioactive mediator secreted by adipocytes, thereby considering apelin-APJ signaling pathways as being promising therapeutic targets in metabolic diseases, like type 2 diabetes (T2D) and obesity [6,7,8].